Plasma CellsMultiple MyelomaBone MarrowBone Marrow TransplantationParaproteinemiasBone Marrow CellsTransplantation, HomologousPrognosisFlow CytometryParaproteinsB-LymphocytesBone and BonesTransplantation, AutologousGraft vs Host DiseaseLiver TransplantationAmyloidosisHematopoietic Stem Cell TransplantationWhole-Body IrradiationTransplantation ConditioningKidney TransplantationTransplantation ChimeraGraft SurvivalAnemia, AplasticHematopoietic Stem CellsBone Marrow DiseasesLeukemiaTissue DonorsBone Marrow PurgingBone Marrow ExaminationBone RemodelingBusulfanHistocompatibility TestingBone Marrow NeoplasmsTransplantation, IsogeneicHematopoiesisMice, Inbred C57BLHistocompatibilityHeart TransplantationStem Cell TransplantationCyclophosphamideGraft RejectionTime FactorsLung TransplantationTreatment OutcomeRecurrenceRadiation ChimeraLeukemia, Plasma CellImmunosuppressive AgentsTransplantation ImmunologyBone DensityCombined Modality TherapyLeukemia, Myeloid, AcuteCell DifferentiationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic NeoplasmsRemission InductionColony-Forming Units AssayImmunosuppressionOrgan TransplantationBone ResorptionPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, MyeloidT-LymphocytesRetrospective StudiesAcute DiseaseHepatic Veno-Occlusive DiseaseLymphocyte DepletionLymphoma, Non-HodgkinGraft vs Host ReactionSurvival AnalysisMyelodysplastic SyndromesCells, CulturedSpleenChimeraCell TransplantationLeukocyte TransfusionHLA AntigensBone NeoplasmsCyclosporinePancreas TransplantationSevere Combined ImmunodeficiencyIslets of Langerhans TransplantationMice, Inbred BALB CHematologic DiseasesFollow-Up StudiesTransplantationNeoplasms, Plasma CellPancytopeniaSurvival RateAntigens, CD34Leukocyte CountAntineoplastic Combined Chemotherapy ProtocolsGranulocyte Colony-Stimulating FactorLymphocyte TransfusionActuarial AnalysisCord Blood Stem Cell TransplantationBone DiseasesMelphalanBone DevelopmentImmunophenotyping